iNGNN-DTI: prediction of drug-target interaction with interpretable nested graph neural network and pretrained molecule models

Bioinformatics. 2024 Mar 4;40(3):btae135. doi: 10.1093/bioinformatics/btae135.

Abstract

Motivation: Drug-target interaction (DTI) prediction aims to identify interactions between drugs and protein targets. Deep learning can automatically learn discriminative features from drug and protein target representations for DTI prediction, but challenges remain, making it an open question. Existing approaches encode drugs and targets into features using deep learning models, but they often lack explanations for underlying interactions. Moreover, limited labeled DTIs in the chemical space can hinder model generalization.

Results: We propose an interpretable nested graph neural network for DTI prediction (iNGNN-DTI) using pre-trained molecule and protein models. The analysis is conducted on graph data representing drugs and targets by using a specific type of nested graph neural network, in which the target graphs are created based on 3D structures using Alphafold2. This architecture is highly expressive in capturing substructures of the graph data. We use a cross-attention module to capture interaction information between the substructures of drugs and targets. To improve feature representations, we integrate features learned by models that are pre-trained on large unlabeled small molecule and protein datasets, respectively. We evaluate our model on three benchmark datasets, and it shows a consistent improvement on all baseline models in all datasets. We also run an experiment with previously unseen drugs or targets in the test set, and our model outperforms all of the baselines. Furthermore, the iNGNN-DTI can provide more insights into the interaction by visualizing the weights learned by the cross-attention module.

Availability and implementation: The source code of the algorithm is available at https://github.com/syan1992/iNGNN-DTI.

MeSH terms

  • Algorithms*
  • Benchmarking
  • Drug Delivery Systems
  • Drug Interactions
  • Neural Networks, Computer*